Codexis to Participate in Cantor Global Healthcare Conference 2026

Rhea-AI Summary

Codexis (NASDAQ: CDXS) will participate in the Cantor Global Healthcare Conference 2026, held September 9-11, 2026, in New York. Management is scheduled for a fireside chat on Thursday, September 10, 2026, at 9:45 a.m. ET, with a live webcast and 90-day replay via Codexis’ investor relations website.

News Market Reaction – CDXS

+0.61%

+0.61% Session close to close

In the Aug 27 session, CDXS gained 0.61%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The prior 8.11% 24-hour move after Codexis’ Q2 2026 earnings provides the platform comparison for th...

Analysis

The prior 8.11% 24-hour move after Codexis’ Q2 2026 earnings provides the platform comparison for this conference appearance. The notice adds no operating update; low short positioning and recent director selling are relevant watch items.

Key Figures

Conference dates: September 9-11, 2026 Fireside chat: September 10, 2026 at 9:45 am ET Replay availability: 90 days

3 metrics

Conference dates September 9-11, 2026 Cantor Global Healthcare Conference 2026

Fireside chat September 10, 2026 at 9:45 am ET Management participation at the conference

Replay availability 90 days Webcast replay following the event

Historical Context

5 past events · Latest: Aug 11 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Aug 11	Earnings report	Positive	+8.1%	Narrower loss, improved margin, reiterated guidance, and extended operating cash outlook
Aug 03	Advisory appointment	Positive	+3.6%	Added technical and industry expertise to support oligonucleotide manufacturing growth
Jul 28	Earnings scheduling	Neutral	-3.2%	Announced the date and webcast details for second-quarter financial results
Jul 23	Stock offering	Negative	-25.6%	Priced 16,666,667 shares at $1.50 for approximately $23.1 million net proceeds
Jul 23	Offering proposal	Negative	-25.6%	Proposed company stock offering with potential additional shares and unspecified terms

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Codexis previously reacted positively to earnings and management news but negatively to offering announcements.

Key Terms

rnai therapeutics, nucleic acid synthesis

2 terms

rnai therapeutics medical

"enable the scaled manufacture of RNAi therapeutics through an enzymatic route."

RNAi therapeutics are medicines that harness a natural cell process called RNA interference to silence specific genes by destroying or blocking the messenger RNA that carries instructions for making a protein—think of removing a recipe from a cookbook so the dish is no longer made. Investors care because this approach can create highly targeted treatments for diseases, offering potential for breakthrough drugs, faster development paths and distinct market or patent advantages, while carrying technical and regulatory risks.

nucleic acid synthesis technical

"small molecule pharmaceuticals manufacturing and nucleic acid synthesis."

Nucleic acid synthesis is the biological or laboratory process of building DNA or RNA, the molecules that store and carry genetic instructions—think of it as writing or copying the recipe book that controls cells. Investors care because the ability to design, manufacture or manipulate these molecules underpins many drugs, vaccines, diagnostic tests and gene therapies; improvements or setbacks in this capability can change development timelines, costs, regulatory risk and market potential.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

REDWOOD CITY, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today announced the Company will attend the Cantor Global Healthcare Conference 2026, being held September 9-11, 2026, in New York, New York.

Management will participate in a fireside chat on Thursday, September 10, 2026, at 9:45 am ET. A live webcast of the event will be available in the Investor Relations section of the Company’s website, https://ir.codexis.com. A replay will be archived for 90 days following the event.

About Codexis

Codexis^® is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, leveraging its proprietary CodeEvolver^® technology to discover, develop and enhance novel, high-performance enzymes. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis^® Manufacturing Platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing, and greater sensitivity in genomic and diagnostic applications. For more information, visit  https://www.codexis.com.

For More Information

Investor Contact
Georgia Erbez
(650) 421-8100
ir@codexis.com

FAQ

When will Codexis (NASDAQ: CDXS) present at the Cantor Global Healthcare Conference 2026?

Codexis management will participate in a fireside chat on September 10, 2026, at 9:45 a.m. ET. According to Codexis, this session is part of the Cantor Global Healthcare Conference 2026 being held September 9-11, 2026, in New York, New York.

How can investors access the Codexis (CDXS) fireside chat webcast from the Cantor Global Healthcare Conference 2026?

Investors can watch a live webcast of Codexis’ fireside chat through the Investor Relations section of the Codexis website. According to Codexis, the webcast link will be posted at https://ir.codexis.com for real-time viewing during the conference session.

Will there be a replay of Codexis’ Cantor Global Healthcare Conference 2026 presentation for CDXS shareholders?

Yes, a replay of Codexis’ fireside chat will be archived for 90 days. According to Codexis, investors can access this replay via the Investor Relations section of the company’s website after the live event has concluded.

Where is the Cantor Global Healthcare Conference 2026 featuring Codexis (CDXS) being held?

The Cantor Global Healthcare Conference 2026, where Codexis will participate, is being held in New York, New York. According to Codexis, the conference runs from September 9-11, 2026, and includes the company’s fireside chat on September 10.

What type of session will Codexis (CDXS) hold at the Cantor Global Healthcare Conference 2026?

Codexis management will take part in a fireside chat at the conference. According to Codexis, this discussion format is scheduled for Thursday, September 10, 2026, at 9:45 a.m. ET and will be accessible via live webcast to investors.

Where can investors find more information about Codexis (NASDAQ: CDXS) around the time of the Cantor Global Healthcare Conference 2026?

Investors can find more information about Codexis on the company’s main website, https://www.codexis.com. According to Codexis, additional investor-specific materials and the webcast link are available in the Investor Relations section at https://ir.codexis.com.